Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:433-437
doi: 10.1161/hy02t2.102991
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasunari, K.
Right arrow Articles by Yoshikawa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasunari, K.
Right arrow Articles by Yoshikawa, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors

(Hypertension. 2002;39:433.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Pressure Promotes Angiotensin II–Mediated Migration of Human Coronary Smooth Muscle Cells Through Increase in Oxidative Stress

Kenichi Yasunari; Kensaku Maeda; Munehiro Nakamura; Junichi Yoshikawa

From the Department of Cardiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.

Correspondence to Kenichi Yasunari, MD, Department of Cardiology, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. E-mail yasunari{at}osaka.med.or.jp

Angiotensin II–mediated oxidative stress may play a role in the pathogenesis of coronary atherosclerosis. We examined the effects of pressure on the angiotensin II–mediated increase in oxidative stress and migration of cultured human coronary smooth muscle cells (SMCs). Increased pressure (100 mm Hg) by helium gas for 48 hours increased angiotensin II–mediated oxidative stress as evaluated by flow cytometry and SMC migration (from 15.9±2.2 to 32.0±2.4 cells per 4 high-power fields, P<0.05; n=8). The pressure-induced increases in oxidative stress observed appear to involve phospholipase D (PLD) and protein kinase C (PKC), inasmuch as the indirect PLD inhibitor suramin, at 100 µmol/L, and the PKC inhibitor chelerythrine, at 1 µmol/L, completely blocked the increase in angiotensin II–mediated oxidative stress induced by pressure. Pressure-induced increase in angiotensin II–mediated oxidative stress was inhibited by diphenylene iodonium chloride, an NADPH oxidase inhibitor, by 79% (P<0.05, n=8). Losartan (1 µmol/L), its active metabolite E3174 (1 µmol/L), and the antioxidant N-acetylcysteine (100 mmol/L) but not PD123319 (1 µmol/L) also blocked pressure-induced increases in angiotensin II–mediated oxidative stress and SMC migration (P<0.05, n=8). These findings suggest a novel cellular mechanism whereby pressure regulates the angiotensin II–mediated migration of SMCs, possibly via angiotensin II type 1 receptors, and which involves PLD-mediated, PKC-mediated, and NADPH oxidase–mediated increases in oxidative stress.


Key Words: oxidative stress • coronary disease • atherosclerosis




This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
M. Labios, M. Martinez, F. Gabriel, V. Guiral, F. Dasi, B. Beltran, and A. Munoz
Superoxide dismutase and catalase anti-oxidant activity in leucocyte lysates from hypertensive patients: effects of eprosartan treatment
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2009; 10(1): 24 - 30.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Zeng, Q. Zhou, F. Yao, S. T. O'Rourke, and C. Sun
Endothelin-1 Regulates Cardiac L-Type Calcium Channels via NAD(P)H Oxidase-Derived Superoxide
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Brandes and J. Kreuzer
Vascular NADPH oxidases: molecular mechanisms of activation
Cardiovasc Res, January 1, 2005; 65(1): 16 - 27.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Morita, K. Iizuka, K. Okita, T. Oikawa, K. Yonezawa, T. Nagai, Y. Tokumitsu, T. Murakami, A. Kitabatake, and H. Kawaguchi
Exposure to pressure stimulus enhances succinate dehydrogenase activity in L6 myoblasts
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1064 - E1069.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Lassegue and R. E. Clempus
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R277 - R297.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J.-M. Li and A. M. Shah
ROS Generation by Nonphagocytic NADPH Oxidase: Potential Relevance in Diabetic Nephropathy
J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S221 - 226.
[Abstract] [Full Text] [PDF]